Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chemotherapy in gastric cancer.
Wöll E, Devries A, Eisterer W, Hejna M, Keil F, Stein H, Zacherl J, Greil R. Wöll E, et al. Among authors: eisterer w. Anticancer Res. 2008 Mar-Apr;28(2B):1213-9. Anticancer Res. 2008. PMID: 18505058 Free article. Review.
[Treatment of extensive disease].
Ploner F, Eisterer W. Ploner F, et al. Among authors: eisterer w. Wien Med Wochenschr. 2009;159(15-16):403-7. doi: 10.1007/s10354-009-0690-8. Wien Med Wochenschr. 2009. PMID: 19696985 Review. German.
[Consensus diagnosis and therapy of soft tissue sarcoma].
Brodowicz T, Amann G, Leithner A, Sztankay A, Kainberger F, Eisterer W, Liegl-Atzwanger B, Rachbauer F, Rath T, Bergmann M, Funovics PT, Ploner F, Windhager R. Brodowicz T, et al. Among authors: eisterer w. Wien Klin Wochenschr. 2012 Feb;124(3-4):85-99. doi: 10.1007/s00508-011-0079-8. Epub 2011 Oct 28. Wien Klin Wochenschr. 2012. PMID: 22038378 German.
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG; GRID study investigators. Demetri GD, et al. Lancet. 2013 Jan 26;381(9863):295-302. doi: 10.1016/S0140-6736(12)61857-1. Epub 2012 Nov 22. Lancet. 2013. PMID: 23177515 Free PMC article. Clinical Trial.
Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria.
Bareck E, Ba-Ssalamah A, Brodowicz T, Eisterer W, Häfner M, Högenauer C, Kastner U, Kühr T, Längle F, Liegl-Atzwanger B, Schoppmann SF, Widmann G, Wrba F, Zacherl J, Ploner F; Austrian representatives of Medical and Surgical Oncology, Pathology, Radiology, Nuclear Medicine, Gastroenterology, and Laboratory Medicine. Bareck E, et al. Among authors: eisterer w. Wien Med Wochenschr. 2013 Mar;163(5-6):137-52. doi: 10.1007/s10354-013-0187-3. Epub 2013 Mar 19. Wien Med Wochenschr. 2013. PMID: 23508516
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial.
Mir O, Brodowicz T, Italiano A, Wallet J, Blay JY, Bertucci F, Chevreau C, Piperno-Neumann S, Bompas E, Salas S, Perrin C, Delcambre C, Liegl-Atzwanger B, Toulmonde M, Dumont S, Ray-Coquard I, Clisant S, Taieb S, Guillemet C, Rios M, Collard O, Bozec L, Cupissol D, Saada-Bouzid E, Lemaignan C, Eisterer W, Isambert N, Chaigneau L, Cesne AL, Penel N. Mir O, et al. Among authors: eisterer w. Lancet Oncol. 2016 Dec;17(12):1732-1742. doi: 10.1016/S1470-2045(16)30507-1. Epub 2016 Oct 14. Lancet Oncol. 2016. PMID: 27751846 Clinical Trial.
104 results